Scott Requadt
2022
In 2022, Scott Requadt earned a total compensation of $4.3M as Former Chief Executive Officer and Former Director at Tourmaline Bio, a 481% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $191,210 |
---|---|
Option Awards | $3,253,600 |
Salary | $580,000 |
Stock Awards | $308,800 |
Other | $12,200 |
Total | $4,345,810 |
Requadt received $3.3M in option awards, accounting for 75% of the total pay in 2022.
Requadt also received $191.2K in non-equity incentive plan, $580K in salary, $308.8K in stock awards and $12.2K in other compensation.
Rankings
In 2022, Scott Requadt's compensation ranked 772nd out of 5,760 executives tracked by ExecPay. In other words, Requadt earned more than 86.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 772 out of 5,760 | 87th |
Division Manufacturing | 348 out of 3,136 | 89th |
Major group Chemicals And Allied Products | 116 out of 1,422 | 92nd |
Industry group Drugs | 103 out of 1,323 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 24 out of 291 | 92nd |
Source: SEC filing on April 19, 2024.
Requadt's colleagues
We found two more compensation records of executives who worked with Scott Requadt at Tourmaline Bio in 2022.